Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Procter & Gamble Stock Rises on Earnings Beat
Johnson & Johnson stock down despite beat on full-year, Q4 2024 earnings
Johnson & Johnson ( JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to about $143 per share.
J&J’s stock surrenders early gains as weak sales guidance offsets earnings beat
Johnson & Johnson’s stock reversed gains made early Wednesday immediately after earnings were released, after the medical technology and drug company beat estimates for the fourth quarter, but offered some mixed guidance.
Procter & Gamble Stock Rises on Earnings Beat: What to Know
Procter & Gamble is trading near the top of the Dow Wednesday after the consumer staples giant beat expectations for its fiscal 2025 second quarter.
Procter & Gamble Earnings Beat Estimates
Procter & Gamble topped expectations in fiscal 2025's Q2 with strong revenue figures, but it continues to face challenges with supply chain costs.
Procter & Gamble earnings beat estimates as shoppers buy more household staples
Procter & Gamble on Wednesday reported quarterly earnings and revenue that beat analysts' expectations, thanks to growing demand for household staples like toilet paper and laundry products. Shares of the company rose 2.5% in premarket trading.
Procter & Gamble Stock Gains After Sales Exceed Expectations
Key Takeaways Procter & Gamble posted fiscal 2025 second-quarter net sales above analysts' expectations.The company's Baby, Feminine & Family Care segment saw sales rise 3%.Shares of the Tide and Pampers parent rose 3% Wednesday following the results.
Procter & Gamble Stock Jumps on Sales and Earnings Beat
Procter & Gamble stock rose in premarket trading Wednesday after the consumer-staples company reported fiscal second-quarter sales and earnings that surpassed Wall Street expectations. Shares of Procter & Gamble were up 3% to $166.
Procter & Gamble Stock Gains as Q2 Earnings & Sales Beat Estimates
The Procter & Gamble Company PG has reported second-quarter fiscal 2025 results, wherein sales and earnings surpassed the Zacks Consensus Estimate and improved year over year. The company’s organic sales grew year over year,
6h
Tesla Gears Up to Report Q4 Earnings: Here's What to Expect
The Zacks Consensus Estimate for TSLA's fourth-quarter earnings and revenues is pegged at 76 cents per share and $27.61 ...
1h
on MSN
Is Netflix Stock Still a Buy After Earnings, Price Hikes?
Analysts were bullish on Netflix stock ahead of its earnings beat, but what is Wall Street saying now? We take a closer look.
2h
How To Earn $500 A Month From GE Aerospace Stock Ahead Of Q4 Earnings
GE Aerospace (NYSE:GE) will release its fourth-quarter financial results before the opening bell on Thursday, Jan. 23.
2d
on MSN
What Analysts Think of P&G Stock Ahead of Earnings
Proctor & Gamble is set to report fiscal second-quarter earnings before the opening bell Wednesday, with analysts calling for ...
Hosted on MSN
2h
Comerica Q4 Earnings Miss Estimates on Lower NII, Fee Income Rises Y/Y
Comerica Incorporated CMA reported fourth-quarter 2024 adjusted earnings per share (EPS) of $1.2, missing the Zacks Consensus ...
14h
SBC-Fueled Cash Flows And Weak Growth Make Snap A Sell Into Earnings
Snap's valuation appears egregious, with EV/EBITDA indicating it's the most expensive among peers. See here to know why we ...
23h
Seagate: Fiscal Q2 Earnings Snapshot
SINGAPORE — SINGAPORE — Seagate Technology Holdings plc (STX) on Tuesday reported fiscal second-quarter earnings of $336 million. On a per-share basis, the Singapore-based company said it had net ...
3h
on MSN
Abbott Laboratories Stock Turns Positive. What to Know From Its Earnings.
Abbott Laboratories posts total worldwide sales of $10.97 billion for the quarter ended Dec. 31, missing Wall Street ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Johnson & Johnson
Procter & Gamble
Peoples Bancorp
EPS
Feedback